About Leuko
Leuko is a company based in Boston (United States) founded in 2017 by Carlos Castro Gonzalez, Alvaro Sanchez-Ferro, Aurelien Bourquard, and Ian Butterworth.. Leuko has raised $6.8 million across 4 funding rounds from investors including NIH, HHS and Good Growth Capital. Leuko offers products and services including PointCheck and A.I. Algorithms.
- Headquarter Boston, United States
- Founders Carlos Castro Gonzalez, Alvaro Sanchez-Ferro, Aurelien Bourquard, Ian Butterworth
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Leuko Labs Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$6.8 M (USD)
in 4 rounds
-
Latest Funding Round
$4.5 M (USD), Grant
Jul 23, 2024
-
Investors
NIH
& 6 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Leuko
Leuko offers a comprehensive portfolio of products and services, including PointCheck and A.I. Algorithms. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
A device is developed for non-invasive monitoring of white blood cell levels, intended for use in home environments to assess infection risks.
Algorithms are employed to analyze blood cell data captured by the device, aiding in the determination of elevated infection risks.
Funding Insights of Leuko
Leuko has successfully raised a total of $6.8M across 4 strategic funding rounds. The most recent funding activity was a Grant round of $4.5 million completed in July 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Grant — $4.5M
-
First Round
First Round
(12 Jul 2018)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2024 | Amount | Grant - Leuko | Valuation |
investors |
|
| Sep, 2022 | Amount | Series A - Leuko | Valuation |
investors |
|
| Feb, 2019 | Amount | Seed - Leuko | Valuation | Good Growth Capital |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Leuko
Leuko has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include NIH, HHS and Good Growth Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
HTH is engaged in investing in health technology startups.
|
Founded Year | Domain | Location | |
|
Early-stage investments are made in life sciences and technologies.
|
Founded Year | Domain | Location | |
|
Venture capital investments are provided by IAG Capital Partners.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Leuko
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Leuko
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Leuko Comparisons
Competitors of Leuko
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Leuko
When was Leuko founded?
Leuko was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Where is Leuko located?
Leuko is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Who is the current CEO of Leuko?
Carlos Castro Gonzalez is the current CEO of Leuko. They have also founded this company.
Is Leuko a funded company?
Leuko is a funded company, having raised a total of $6.8M across 4 funding rounds to date. The company's 1st funding round was a Seed of $1.8M, raised on Jul 12, 2018.
What does Leuko do?
Leuko was founded in 2017 and is headquartered in Boston, United States. Operations focus on the medical device sector, where a non-invasive device for monitoring white blood cell counts is developed and produced. This technology supports hematology diagnostics in healthcare settings. The company was established by co-founders including Carlos Castro Gonzalez as CEO, Alvaro Sanchez-Ferro, Aurelien Bourquard, and Ian Butterworth. Activities are centered on advancing point-of-care testing solutions. (68 words).
What products or services does Leuko offer?
Leuko offers PointCheck and A.I. Algorithms.
Who are Leuko's investors?
Leuko has 7 investors. Key investors include NIH, HHS, Good Growth Capital, HTH, and IAG Capital Partners.